Background The Hypereosinophilic Syndromes (HES) are a heterogeneous group of rare diseases characterized by blood hypereosinophilia and eosinophil-related organ damage with the Churg-Strauss syndrome as the vasculitic form of disease. Cardiac involvement was reported in 20-50% in earlier series. Yet, with improved diagnostic methods, the frequency of cardiac involvement is expected to be even ...
